Transforming growth factor-α deficiency reduces pulmonary fibrosis in transgenic mice

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 924-934

  Madtes, David K ^a   Elston, Andrew L ^b   Hackman, Robert C ^b   Dunn, Ashley R ^b   Clark, Joan G ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS MUSCULUS;

BLEOMYCIN; COLLAGEN; DNA; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; PRIMER DNA; RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL; ARTICLE; CELL DIVISION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENETICS; GENOTYPE; LUNG; LUNG FIBROSIS; METABOLISM; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BLEOMYCIN; CELL DIVISION; COLLAGEN; DNA; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; GENOTYPE; LUNG; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PULMONARY FIBROSIS; RNA; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0033127103     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3526     Document Type: Article

References (54)

1. Higashiyama S., J. A. Abraham, J. Miller, J. C. Fiddes, and M. Klagsbrun. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939.
2. Todaro, G. J., C. Fryling, and J. E. De Larco. 1980. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc. Natl. Acad. Sci. USA 77: 5258-5262.
3. Derynck, R. 1986. Transforming growth factor-alpha: structure and biological activities. J. Cell. Biochem. 32:293-304.
4. De Larco, J. E., and G. J. Todaro. 1978. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 75:4001-4005.
5. Schreiber, A. B., M. E. Winkler, and R. Derynck. 1986. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 232:1150-1253.
6. Silver, M. H., J. C. Murray, and R. M. Pratt. 1984. Epidermal growth factor stimulates type-V collagen synthesis in cultured murine palatal shelves. Differentiation 27:205-208.
7. Turley, E. A., M. D. Hollenberg, and R. M. Pratt. 1985. Effect of epidermal growth factor/urogastrone on glycosaminoglycan synthesis and accumulation in vitro in the developing mouse palate. Differentiation 28:279-285.
8. Turksen, K., Y. Choi and E. Fuchs. 1991. Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures. Cell. Regul. 2:613-625.
9. Hosono, T., A. Ito, T. Sato, H. Nagase, and Y. Mori. 1996. Translational augmentation of pro-matrix metalloprotinease 3 (prostromelysin 1) and a tissue inhibitor of metalloproteinases (TIMP)-1 mRNAs by epidermal growth factor and transforming growth factor α, but not by interleukin-1α or 12-O-tetradecanoylphorbol 13-acetate in human uterine cervical fibroblasts: the possible involvement of an atypical protein kinase C. Biol. Pharm. Bull. 19:1285-1290.
10. 1 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J. Biol. Chem. 268:19143-19151.
11. Leco, K. J., R. Khokha, N. Pavloff, S. P. Hawkes, and D. R. Edwards. 1994. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269:9352-9360.
12. Madtes, D. K., H. K. Busby, T. P. Strandjord, and J. G. Clark. 1994. Expression of transforming growth factor-α and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am. J. Respir. Cell Mol. Biol. 11:540-551.
13. Vivekananda, J., A. Lin, J. J. Coalson, and R. J. King. 1994. Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-α. J. Biol. Chem. 269:25057-25061.
14. Absher, M., M. Sjostrand, L. C. Baldor, D. R. Hemenway, and J. Kelly. 1993. Patterns of secretion of transforming growth factor-α (TGF-α) in experimental silicosis: acute and subacute effects of cristobalite exposure in the rat. Reg. Immunol. 5:225-231.
15. Korfhagen, T. R., R. J. Swantz, S. E. Wert, J. M. McCarty, C. B. Kerlakian, S. W. Glasser, and J. A. Whitsett. 1994. Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J. Clin. Invest. 93:1691-1699.
16. Chesnutt, A., F. Kheradmand, H. G. Folkesson, M. A. Alberts, and M. A. Matthay. 1997. Soluble transforming growth factor-α is present in the pulmonary edema fluid of patients with acute lung injury. Chest 111:652-656.
17. Madtes, D. K., G. Rubenfeld, L. D. Klima, J. A. Milberg, K. P. Steinberg, T. R. Martin, G. Raghu, L. D. Hudson, and J. G. Clark. 1998. Elevated transforming growth factor-α levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 111:424-430.
18. Mann, G. B., K. J. Fowler, A. Gabriel, E. C. Nice, R. L. Williams, and A. R. Dunn. 1993. Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation. Cell 73:249-261.
19. Ohnishi, S. T., and J. K. Barr. 1978. A simplified method of quantitating protein using the biuret and phenol reagents. Anal. Biochem. 86:193-200.
20. Schrier, D. J., R. G. Kunkel, and S. H. Phan. 1983. The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am. Rev. Respir. Dis. 127:63-66.
21. Woessner, J. F., Jr. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93:440-447.
22. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
23. Strandjord, T. P., J. G. Clark, W. A. Hodson, R. A. Schmidt, and D. K. Madtes. 1993, Expression of transforming growth factor-α in mid-gestation human fetal lung. Am. J. Respir. Cell Mol. Biol. 8:266-272.
24. Aguayo, S. M., W. E. Schuyler, J. J. Murtagh, and J. Roman. 1994. Regulation of lung branching morphogenesis by bombesin-like peptides and neutral endopeptidase. Am. J. Respir. Cell Mol. Biol. 10:635-642.
25. Melton, D. A., M. R. Krieg, M. R. Kebagliali, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage RNA SP6 promoter. Nucleic Acids Res. 12:7035-7056.
26. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
27. Rao, C. R. 1973. Linear Statistical Inference and Its Applications. John Wiley & Sons, New York. 388.
28. Luetteke, N. C., T. H. Qiu, R. L. Peiffer, P. Oliver, O. Smithies, and D. C. Lee. 1993. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 73:263-278.
29. 1H]thymidine administered by injection or osmotic pump. Carcinogenesis 11:2245-2251.
30. Phan, S. H., and S. L. Kunkel. 1992. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:29-43.
31. Smith, R. E., R. M. Strieter, S. H. Phan, N. W. Lukacs, G. B. Huffnagle, C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanoff, and S. L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-1α in bleomycin-induced lung injury. J. Immunol. 153:4704-4712.
32. Hrieland, J. K., M. L. Jones, C. M. Flory, G. R. Miller, J. S. Warren, S. H. Phan, and J. C. Fantone. 1993. Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury. Am. J. Respir. Cell Mol. Biol. 9:300-305.
33. Walsh, J., M. Absher, J. Kelley, and L. Baldor. 1993. Variable expression of platelet-derived growth factor family proteins in acute lung injury. Am. J. Respir. Cell Mol. Biol. 9:637-644.
34. Khalil, N., O. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-731.
35. Laskin, D. L., J. D. Laskin, I. B. Weinstein, and R. A. Carchman. 1981. Induction of chemotaxis in mouse peritoncal macrophages by phorbol ester tumor promoters. Cancer Res. 41:1923-1928.
36. Federspiel, S. J., S. J. DiMari, A. M. Howe, M. L. Guerry-Force, and M. A. Haralson. 1991. Extracellular matrix biosynthesis by cultured fetal rat lung epithelial cells: III. Effects of chronic exposure to epidermal growth factor on growth, differentiation, and collagen biosynthesis. Lab. Invest. 64:463-473.
37. Danielpour, D., K. Y. Kim, T. S. Winokur, and M. B. Sporn. 1991. Differential regulation of the expression of transforming growth factor-βs 1 and 2 by retinoic acid, epidermal growth factor, and dexamethasone in NRK-49F and A549 cells. J. Cell. Physiol. 148:235-244.
38. Hardie, W. D., M. D. Bruno, K. M. Huelsman, H. S. Iwamoto, P. E. Carrigan, G. D. Leikauf, J. A. Whitsett, and T. R. Korfhagen. 1997. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-α. Am. J. Pathol. 151:1075-1083.
39. Abraham, J. A., D. Damm, A Bajardi, J. Miller, M. Klagsbrun, and R. A. Ezekowitz. 1993. Heparin-binding EGF-like growth factor, characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem. Biophys. Res. Commun. 190:125-133.
40. Powell, P. P., M. Klagsbrun, J. A. Abraham, and R. C. Jones. 1993. Eosinophils expressing Heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143: 784-793.
41. Strandjord, T. P., J. G. Clark, D. E. Guralnick, and D. K. Madtes. 1995. Immunolocalization of transforming growth factor-α, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung. Pediatr. Res. 38:851-856.
42. Sannes, P. L., K. K. Burch, and J. Khosla. 1992. Immunohistochemical localization of epidermal growth factor and acidic and basic fibroblast growth factors in postnatal developing and adult rat lungs. Am. J. Respir. Cell Mol. Biol. 7:230-237.
43. Raaberg, L., S. S. Pouslen, and E. Nexo. 1991. Epidermal growth factor in the rat lung. Histochemistry 95:471-475.
44. Strandjord, T. P., J. G. Clark, and D. K. Madtes. 1994. Expression of TGF-α, EGF and EGF receptor in fetal rat lung. Am. J. Physiol. (Lung Cell. Mol. Physiol.) 267:L364-L389.
45. Raaberg, L., E. Nexo, S. Buekley, W. Luo, M. L. Snead, and D. Warburton. 1992. Epidermal growth factor transcription, translation, and signal transduction in rat type II pneumocytes in culture. Am. J. Respir. Cell Mol. Biol. 6:44-49.
46. Pratt, P. C. R. T. Vollmer, J. D. Shelburne, and J. D. Carpo. 1979. Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenation project. Am. J. Pathol. 95:191-214.
47. Zapol, W. M., R. L. Trelstad, J. W. Coffe, I. Tsai, and R. A. Salvador. 1979. Pulmonary fibrosis in severe acute respiratory failure. Am. Rev. Respir. Dis. 119:547-554.
48. Hill, J. D. J. L. Ratliff, J. C. W. Parrott, M. Lamy, R. J. Fallat, E. Koeniger, E. McGee Yaeger, and G. Whitmer, 1976. Pulmonary pathology in acute respiratory insufficiency: lung biopsy as a diagnostic tool. J. Thorac. Cardiovas. Surg. 71:64-71.
49. Martin, C., L. Papazian, M. J. Payan, P. Saux, and F. Gouin. 1995. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. Chest 107:196-200.
50. Carrington, C. B., E. A. Gaensler, R. E. Countu, M. X. FitzGerald, and R. G. Gupta. 1978. Natural history and treated course of usual and desquamative interstitial pneumonia. N. Engl. J. Med. 298:801-809.
51. Winterbauer, R. H., S. P. Hammar, K. O. Hallman, J. E. Hays, N. E. Pardee, E. H. Morgan, J. D. Allen, K. D. Moores, W. Bush, and J. H. Walker. 1978. Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine. Am. J. Med. 64:661-672.
52. Raghu, G., W. J. Depaso, K. Cain, S. P. Hammar, C. E. Wetzel, D. F. Dreis, J. Hutchinson, N. E. Pardee, and R. H. Winterbauer. 1991. Azathioprine combined with prednisonc in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am. Rev. Respir. Dis. 144:291-296.
53. Gay, S. E., E. A. Kazerooni, G. B. Tocws, J. P. Lynch, B. H. Gross, P. N. Cascade, D. L. Spizarny, A. Flint, M. A. Schork, R. I. Whyte, J. Popovich, R. Hyzy, and F. J. Martinez. 1998. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am. J. Respir. Crit. Care Med. 157: 1063-1072.
54. McHugh, L. G., J. A. Milberg, M. E. Whilcomb, R. B. Schoene, R. J. Maunder, and L. D. Hudson. 1994. Recovery of function in survivors of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:90-94.